Italian study shows no improvement from Roche's rheumatoid arthritis drug for COVID-19
Roche Holding AG's Actemra did not improve symptoms in patients with early-stage COVID-19 pneumonia, scientists conducting a study of the drug in Italy said on Wednesday, raising questions about the potential of the Swiss drugmakers' rheumatoid arthritis drug to treat the novel coronavirus. [Source]
Publication Date:Origin: reuters.com
Category: companyNews
Topics: arthritis, rheumatoid, study, novel coronavirus, treat, drugmakers', the Swiss, potential, questions, raising, Italy said, conducting, scientists, COVID-19 pneumonia, early-stage, patients, symptoms, improve, did not, Actemra, Holding, Roche, COVID-19, Roche's, improvement, shows, Italian